Announcements Trials
Browse Landscape

Status

Completed 10Unknown 4Active not recruiting 4Recruiting 3Enrolling by invitation 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Cardiotoxicity 3Breast Neoplasms 2Ventricular Dysfunction 1Neoplasms 1Heart Failure 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Observational × Echocardiography × Clear all
NCT06664528 2025-03-04

CV_CANCER

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
300 enrolled

Neoplasms, Cardiotoxicity

NCT05851053 2024-05-29

BLOC-II

University Medical Center Groningen

Recruiting
455 enrolled
Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT06282796 2024-02-28

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

First Hospital of China Medical University

Recruiting
600 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡